Palmer S , Groves N , Schindeler A , Yeoh T , Biben C , Wang CC , Sparrow DB , Barnett L , Jenkins NA , Copeland NG , Koentgen F , Mohun T , Harvey RP .

R03 AG14811 NIA NIH HHS , Wellcome Trust

	Figure 1. (A) DNA sequence of mouse Csl cDNA with predicted protein. (B) Alignment of human, mouse, rat, and Xenopus Csl proteins. Shaded amino acids indicate nonidentity. (Csl cDNA sequence data available from GenBank/EMBL/DDBJ under accession nos. AY026524 [mouse] and AF343894 [Xenopus]).
	Figure 2. Csl mRNA expression. (A) RNase protection analysis of Csl and control cyclophilin (Cyclo) mRNAs in adult mouse tissues. (B–K) Whole-mount in situ hybridization using Csl probe on mouse embryos. (B) Ventral view of E8.25 embryo. (C) Section of the embryo shown in B. Arrows indicate expression on the ventral surface of the fusing heart tube. (D) Ventral view of E8.5 embryo. (E) Section of embryo depicted in D showing Csl expression at the outer curvature of the ventricles. (F–H) E10.5 embryo viewed from the ventral and left and right sides, respectively. Arrow in F indicates rib of expression in outflow tract. Arrow in G indicates expression in presumptive left atrial appendage. (I) Section of E10.5 heart. Note that expression is restricted to the outer curvature of the ventricles and atrial appendages. (J) E9.5 Nkx2-5−/− embryos (−/−) compared with wild-type sibling (+/+). (K) E13.5 embryos comparing expression of Csl and myogenin. as, atrial septum; at, atrium; avc, atrioventricular canal; lv, left ventricle; oft, outflow tract; rs, right sinus horn; rv, right ventricle; tb, trabeculae.
	Figure 4. Csl protein expression. (A) Western blot analysis of Csl expression in adult tissues. An equal mass of protein was loaded in each lane. “Blocked” indicates lanes in which Csl antibody was preabsorbed with excess recombinant Csl protein. (B) Western blot analysis of Csl expression in postnatal day (P)1, P8, and P21, and/or adult tissues from wild-type and male CslAPΔ knockout mice using Akt levels as loading control. (C) Comparison of levels of Csl expression in heart and different skeletal muscles using Hsp 70 levels as control. Note the additional Hsp 70 isoform enriched in soleus. (D–F) Immunofluorescence analysis of Csl expression in C2C12 cells after 1, 2, and 4 d, respectively, in differentiation medium. (G) Immunofluorescence on 4-d culture after blocking as in A. bm, bipolar mononuclear myocytes; Diaphm, diaphragm; Gastroc, gastrocnemius; rm, rounded mononuclear myocytes. Bar, 100 μm.
	Figure 3. (A) Csl-targeting construct relative to wild-type and targeted alleles. Large arrowheads indicate direction of LoxP sites. Black shading within exon 2 indicates Csl-coding region. Arrows indicate PCR genotyping primers. hPAP, hPAP gene; pgk-Neo, neomycin resistance gene cassette. (B) Example of multiplex PCR genotyping of targeted (582 bp), wild-type (517 bp), and Cre-deleted (321 bp) alleles. M, MluI; P, PvuII; X, XbaI.
	Figure 5. Tissue distribution of Csl protein. Sections from newborn (A–D) and adult (E–I) mice were analyzed for Csl and/or myosin heavy chains using immunofluorescence (A, B, D–F, H, and I) or for Csl by staining for hPAP (C and G). (A) Section showing expression in heart and adjacent skeletal muscles. (B) Section from a CslAPΔ mouse. (C) Section from CslAPΔ mouse stained for hPAP. Arrowheads show nonspecific staining. (D) Section showing Csl expression in smooth muscle of the stomach. (E and F) Near adjacent sections showing muscle expression of Csl (E) and fast myosin heavy chain IIb (F). (G) Fiber-type pattern of Csl expression in CslAPΔ mouse revealed by hPAP staining. (H and I) Double immunofluorescence showing muscle fiber–type pattern of Csl (H) and slow myosin heavy chain I (I). Arrowheads indicate slow fibers showing the highest Csl fluorescence. Bars indicate length in micrometers. at, atrium; bl, bladder; dm, diaphragm; gs, gastrocnemius; ic, intercostal muscle; li, liver; pl, plantaris; si, small intestine; so, soleus; st, stomach; ve, ventricle. Bars: (A, B, and D) 500 μm; (C) 1 μm; (E–G) 200 μm; (H and I) 100 μm.
	Figure 6. Subcellular localization of Csl protein. (A and B) Double immunofluorescence on a section of E18.5 skeletal muscle showing localization of Csl (A) and α-actinin (B). (C) High power double immunofluorescence confocal image (overlay) of a section of stretched adult soleus (see D–F) showing Csl (green) and α-actinin (red). Arrowheads indicate weak Csl staining over the M-line. (D–F) Double immunofluorescence confocal image of a section of stretched adult soleus showing Csl (D), α-actinin (E), and overlay (F). (G–I) Confocal images of Csl (G) and talin (H) with overlay (I). (J) Overlay of Csl and talin double immunofluorescence in myotendenous junctions (arrowheads). (K and L) Transverse sections of E17.5 myotubes showing Csl (K) and α-actinin (L). (M–O) Double immunofluorescence of Csl (M) and α-actinin (N) with overlay (O) in adult ventricular myocytes. Arrowheads indicate Csl staining over the M-line. mf, myofiber; tn, tendon. Bars: (A, B, D–I, and K–L) 20 μm; (C) 10 μm; (J) 50 μm.
	Figure 7. Effect of constitutive Csl expression in C2C12 myoblasts. (A and B) Phase–contrast images of stable C2C12 clones constitutively expressing GFP (A) or myc-Csl (B). (C) Mean myoblast area (± SEM) of parental C2C12 cells and a series of transfected myc- or FLAG-Csl–expressing clones. GV is transfected with GFP vector only; ME1/2 are lines expressing myc-Csl driven by EF1α promoter; MM1/2 are lines expressing myc-Csl driven by differentiation-dependent MLC1 promoter/enhancer. Only ME1, ME2, and FC18 express Csl in myoblasts. (D) Overlay of forward light scatter histograms from a single experiment in which C2C12 stable clones (GV, ME1, ME2, MM1, MM2) and parental cell line were compared. As positive control, GV cells were resuspended in hypotonic 0.5× PBS causing a rightward shift. (E) Mean forward light scatter (± SEM) determined from three separate experiments and plotted as a percentage of controls. (F) Mean percentage (± SEM) of closure of 150-μm wounds in confluent monolayers after 6 h. (G) Anti-myc antibody immunofluorescence in a myc-Csl–expressing myoblast. (H) GFP fluorescence in a C2C12 myoblast transiently expressing GFP–Csl fusion protein. Bars, 20 μm.
	Figure 8. Effects of constitutive FLAG-Csl expression in differentiating C2C12 myogenic cells. Phase–contrast and immunofluorescence images of control (F5; left panels) and FLAG-Csl–expressing (FC18; right panels) C2C12 cells after 3 d of differentiation. (A and B) No treatment. (C and D) With 100 ng/ml IGF-1. (E and F) With 100 ng/ml IGF-1 plus 1 μM CsA. (G and H) MF20 immunofluorescence on cells treated with IGF-1. Bars, 100 μm.
	Figure 9. Myogenic gene expression and protein to DNA ratios in control (F5) and FLAG-Csl (FC18) C2C12 cells in the presence and absence of IGF-1 (100 ng/ml). (A) Northern blot analysis of total RNA from cells cultured for 0–5 d in differentiation medium using indicated probes. Ethidium bromide (EtBr) staining of 28S and 18S ribosomal RNAs serves as loading control. Two mRNA species are produced from the transgene due to differential 3′ untranlated region processing. (B) Total protein/total DNA ratios ± SEM at different times of differentiation. Myog, myogenin; Mhc, embryonic myosin heavy chain.
	Figure 10. NFAT, MEF2, and calcineurin activity in control (F5) and FLAG-Csl (FC18) cells with and without IGF-1 (100 ng/ml). (A and B) Mean NFAT-dependent transcriptional activity (± SEM) measured using a transfected luciferase reporter gene driven by the myoglobin promoter (Mygb), compared with the same promoter with mutated NFAT-binding sites (Mygb Δ-NFAT). (C and D) Mean MEF2-dependent transcriptional activity (± SEM) measured using a transfected luciferase reporter containing three MEF2-binding sites (3×MEF) compared with the minimal vector (Vector only). (E) Levels of calcineurin phosphatase activity measured in vitro as picomoles of 32P-radiolabeled phosphate released per minute per microgram of extract (pmol/min/μg). (F) Effect of CsA (1 μM) on NFAT activity measured using the wild-type myoglobin (Mygb) reporter at day 4 in FC18 cells after treatment with IGF-1 (left) or after transient transfection of activated calcineurin A subunit (Act-CnA) (right).

Abbott, Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. 1998, Pubmed

Abbott, Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. 1998, Pubmed
Anderson, Clinical anatomy of the atrial septum with reference to its developmental components. 1999, Pubmed
Berthier, Supramolecular organization of the subsarcolemmal cytoskeleton of adult skeletal muscle fibers. A review. 1997, Pubmed
Biben, Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHand during murine heart development. 1997, Pubmed , Xenbase
Biben, Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. 2000, Pubmed , Xenbase
Biben, Homeobox genes and heart development. 1997, Pubmed , Xenbase
Bishop, Rho GTPases and their effector proteins. 2000, Pubmed
Blau, Cytoplasmic activation of human nuclear genes in stable heterocaryons. 1983, Pubmed
Brancaccio, Melusin is a new muscle-specific interactor for beta(1) integrin cytoplasmic domain. 1999, Pubmed
Bruneau, Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. 2000, Pubmed , Xenbase
Chen, The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. 2000, Pubmed
Chen, Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. 1996, Pubmed , Xenbase
Chin, A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. 1998, Pubmed
Christoffels, Chamber formation and morphogenesis in the developing mammalian heart. 2000, Pubmed
Cleaver, Overexpression of the tinman-related genes XNkx-2.5 and XNkx-2.3 in Xenopus embryos results in myocardial hyperplasia. 1996, Pubmed , Xenbase
Coolican, The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. 1997, Pubmed
Copeland, Development and applications of a molecular genetic linkage map of the mouse genome. 1991, Pubmed
Delling, A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. 2000, Pubmed
Doberstein, Genetic analysis of myoblast fusion: blown fuse is required for progression beyond the prefusion complex. 1997, Pubmed
Dunn, Calcineurin is required for skeletal muscle hypertrophy. 1999, Pubmed
Durocher, The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. 1996, Pubmed , Xenbase
Durocher, The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. 1997, Pubmed , Xenbase
Fishman, Fashioning the vertebrate heart: earliest embryonic decisions. 1997, Pubmed
Friday, Calcineurin activity is required for the initiation of skeletal muscle differentiation. 2000, Pubmed
Fu, Vertebrate tinman homologues XNkx2-3 and XNkx2-5 are required for heart formation in a functionally redundant manner. 1998, Pubmed , Xenbase
Goldspink, Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. 1999, Pubmed
Granger, Desmin and vimentin coexist at the periphery of the myofibril Z disc. 1979, Pubmed
Gredinger, Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. 1998, Pubmed
Grieff, Sequence analysis of 139 kb in Xp22.1 containing spermine synthase and the 5' region of PEX. 1997, Pubmed
Grow, Tinman function is essential for vertebrate heart development: elimination of cardiac differentiation by dominant inhibitory mutants of the tinman-related genes, XNkx2-3 and XNkx2-5. 1998, Pubmed , Xenbase
Guo, COUP-TF1 antagonizes Nkx2.5-mediated activation of the calreticulin gene during cardiac development. 2001, Pubmed , Xenbase
Harvey, NK-2 homeobox genes and heart development. 1996, Pubmed
Hirayama, Mouse C2 myoblast cells resist HVJ (Sendai virus)-mediated cell fusion in the proliferating stage but become capable of fusion after differentiation. 1999, Pubmed
Kaibuchi, Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. 1999, Pubmed
Lawlor, Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. 2000, Pubmed
Layne, Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. 1999, Pubmed
Luo, Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. 1994, Pubmed
Lyons, Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. 1995, Pubmed
Millino, Cardiac and smooth muscle cell contribution to the formation of the murine pulmonary veins. 2000, Pubmed
Molkentin, A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. 1998, Pubmed
Musarò, IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. 1999, Pubmed
Musarò, Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. 1999, Pubmed
Nobes, Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. 1995, Pubmed
Pardo, A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. 1983, Pubmed
Park, Differential rescue of visceral and cardiac defects in Drosophila by vertebrate tinman-related genes. 1998, Pubmed
Patzak, Identification, mapping, and genomic structure of a novel X-chromosomal human gene (SMPX) encoding a small muscular protein. 1999, Pubmed
Ranganayakulu, Divergent roles for NK-2 class homeobox genes in cardiogenesis in flies and mice. 1998, Pubmed , Xenbase
Rivkees, Characterization of the murine A1 adenosine receptor promoter, potent regulation by GATA-4 and Nkx2.5. 1999, Pubmed , Xenbase
Rusnak, Calcineurin: form and function. 2000, Pubmed
Schott, Congenital heart disease caused by mutations in the transcription factor NKX2-5. 1998, Pubmed , Xenbase
Schwenk, A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. 1995, Pubmed
Semsarian, Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. 1999, Pubmed
Skerjanc, Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. 1998, Pubmed , Xenbase
Sotiropoulos, Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. 1999, Pubmed
Tanaka, The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. 1999, Pubmed , Xenbase
Wu, MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. 2000, Pubmed
Yagami-Hiromasa, A metalloprotease-disintegrin participating in myoblast fusion. 1995, Pubmed
Yotov, Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor. 1996, Pubmed